Emily Olfson is a physician-scientist whose research focuses on the genetics of childhood-onset psychiatric conditions. She received her MD-PhD from Washington University in St. Louis where her dissertation in Human and Statistical Genetics focused on the genetics of smoking and alcoholism in the laboratory of Dr. Laura Bierut. She then completed residency and fellowship training in child, adolescent, and adult psychiatry in the Yale Solnit Integrated Program. At Yale, Dr. Olfson also pursued research training focused on the neurogenomics of trichotillomania, excoriation disorder, attention-deficit/hyperactivity disorder, and childhood anxiety disorders in the laboratory of Dr. Thomas Fernandez. Under the mentorship of Dr. Fernandez and Dr. Michael Bloch, she has developed the first DNA sequencing study focused on parent-child trios impacted by body-focused repetitive behaviors (tabsstudy.org). Dr. Olfson works clinically with adults and children in the Tic and OCD Program in the Yale Child Study Center. She has received research support from the NIMH, AACAP, IOCDF, Klingenstein Third Generation Foundation, and Alan B. Slifka Foundation through the Riva Ariella Ritvo endowment.
|Career Development Award||National Institute of Mental Health (NIMH)||2022|